JOURNAL OF GENERAL AND APPLIED MICROBIOLOGY, published by the MICROBIOL RES FOUNDATION, is a vital resource in the fields of applied microbiology and biotechnology, as well as in diverse medical applications, serving an academic community dedicated to advancing microbial science. Established in 1955, this journal has a rich history of disseminating innovative research and insights into the intricate world of microorganisms. With an ISSN of 0022-1260 and an E-ISSN of 1349-8037, the journal maintains high scholarly standards and robustness, reflected in its 2023 Scopus rankings placing it in the Q3 and Q4 quartiles within its categories. While primarily based in Japan, the journal engages a global audience, offering valuable contributions that inform both theoretical perspectives and practical applications in microbiology. Despite being a non-open-access publication, it provides pivotal research findings essential for academics, professionals, and students alike, fostering a deeper understanding of microbial impact on health and the environment.

The ISME Journal, published by Oxford University Press, stands as a premier multidisciplinary platform dedicated to advancing the fields of Ecology, Evolution, Behavior, and Systematics as well as Microbiology. With its ISSN of 1751-7362 and E-ISSN 1751-7370, this renowned journal has successfully maintained a prestigious reputation reflected in its commendable Q1 rankings across both fields in 2023. It ranks #7 out of 721 in Ecology, Evolution, Behavior, and Systematics and #8 out of 182 in Microbiology, placing it in the top percentiles of relevant Scopus categories. Covering original research, reviews, and methodologies, the journal aims to foster interdisciplinary collaboration and inspire new paradigms in microbiome research, environmental processes, and evolutionary dynamics. Researchers, professionals, and students are encouraged to submit their findings to a journal that not only reaches a global audience but also influences the direction of ongoing scientific discourse. With a commitment to excellence, the ISME Journal represents an essential resource for anyone engaged in these transformative fields of study.

MICROBIAL PATHOGENESIS, published by Academic Press Ltd - Elsevier Science Ltd, is a prominent journal in the fields of Infectious Diseases and Microbiology, with a notable impact factor and classified in the Q2 quartile for both categories as of 2023. Since its inception in 1986, this journal has provided a platform for the dissemination of cutting-edge research that enhances our understanding of microbial infections and their implications in health and disease. The journal is indexed in Scopus, ranking #80 among 344 in Infectious Diseases and #57 among 182 in Microbiology, underscoring its significant contribution to the scientific community. Although it operates under a traditional subscription model, the content is vital for researchers, professionals, and students focused on the dynamics of microbial pathogenesis and the development of innovative therapeutic strategies. The journal's comprehensive scope aims to foster advancements in this critical area of study, bridging the gap between laboratory research and clinical applications.

Welcome to mLife, an emerging journal at the forefront of microbiological research published by the esteemed WILEY in China. With its ISSN 2097-1699 and E-ISSN 2770-100X, mLife serves as a vital platform for scholars and practitioners aiming to advance their understanding of microbial sciences. With an impressive Q2 ranking in the Microbiology category and a Scopus rank of 143 out of 182, mLife is quickly establishing itself as a valuable source of cutting-edge research. The journal, covering a range of innovative topics from immunology to environmental microbiology, provides an engaging venue for disseminating high-quality research findings aimed at addressing real-world challenges. Authors and readers alike benefit from its accessibility features that encourage scholarly collaboration and information sharing. As we converge on the rich microbial landscapes from 2022 to 2024, mLife is committed to fostering a community dedicated to rigorous research and impactful discoveries.

FOLIA MICROBIOLOGICA is a distinguished academic journal published by SPRINGER, focusing on the intricate realms of microbiology and its contributions to medicine. Since its inception in 1957, the journal has been a vital platform for disseminating pioneering research, addressing contemporary challenges in the field while facilitating discourse among researchers, clinicians, and students alike. With an ISSN of 0015-5632 and an E-ISSN of 1874-9356, FOLIA MICROBIOLOGICA publishes original articles, reviews, and critical insights that span not only traditional microbiological studies but also innovative applications in immunology and biotechnology. The journal is categorized within the esteemed Q2 tier in Medicine (Miscellaneous) and holds a Q3 rating in Microbiology as of 2023, reflecting its significant impact and relevance in the scientific community. Although it does not currently offer open access, it remains a respected resource, enabling professionals and students to keep abreast of advancements from its base in the Netherlands. With a strong commitment to quality and rigorous peer-review, FOLIA MICROBIOLOGICA serves as an essential repository of knowledge, fostering the next generation of microbiologists and medical practitioners.

The Lancet Microbe is a leading peer-reviewed journal published by ELSEVIER, focused on advancing research in the fields of infectious diseases, microbiology, and virology. Since its inception in 2020, this open-access journal has rapidly achieved a prestigious reputation, evidenced by its impressive rankings in the Scopus Ranks, where it holds positions within the top 10 in multiple categories and boasts high percentiles, reflecting the impact and relevance of its published works. With a quarterly publication schedule, the Lancet Microbe aims to disseminate critical findings and foster innovation within the scientific community, providing a platform for researchers and professionals to share their significant contributions. The journal is committed to facilitating knowledge exchange and accessibility, making it an essential resource for academicians and practitioners dedicated to addressing global health challenges.

WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, published by Springer, serves as a pivotal forum for advancing the fields of microbiology and biotechnology since its inception in 1990. Located in the Netherlands, this esteemed journal has secured a prominent position in the academic landscape, recognized for its strong impact factor and prestigious Q2 category rankings across disciplines such as Applied Microbiology, Biotechnology, and Physiological Sciences. Researchers and professionals utilize this journal to disseminate innovative findings and explore emerging technologies that are transforming the scientific landscape. With a robust submission rate and high visibility among the academic community, the journal fosters interdisciplinary collaboration, encouraging discussions that bridge gaps between theory and practical applications. As it converges into 2024, the WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY continues to be a vital resource for scholars aiming to enhance our understanding of microbial processes and biotechnological advances.

Welcome to the Jundishapur Journal of Microbiology, a peer-reviewed publication dedicated to advancing the field of microbiology. Published by BRIEFLAND, this journal focuses on key areas such as infectious diseases and medical microbiology, offering a platform for researchers to share their findings from 2009 to 2024. Despite its current positioning in Quartile 4 across various categories in 2023, the journal provides a valuable resource for budding scientists and established professionals alike, contributing to the growing body of knowledge in these critical areas. While it is not an open-access journal, the Jundishapur Journal prioritizes the dissemination of research in the Netherlands, facilitating a deeper understanding of microbial science and its implications for public health. Join a community of innovators committed to exploring both emerging and established themes in microbiology.

CURRENT OPINION IN MICROBIOLOGY is a prestigious academic journal published by CURRENT BIOLOGY LTD, dedicated to advancing the field of microbiology through timely and insightful reviews. With an ISSN of 1369-5274 and an e-ISSN of 1879-0364, this journal has established itself as a leading source of knowledge in various subfields, consistently achieving a Q1 ranking in Infectious Diseases and Microbiology for 2023. Operating from the United Kingdom, CURRENT OPINION IN MICROBIOLOGY serves a critical role for researchers, clinicians, and students alike by disseminating groundbreaking findings and fostering discussions that shape the future of microbiological research. The journal's rigorous selection process ensures that only high-quality articles are published, reflecting its strong impact factor and high percentile rankings across relevant Scopus categories. Although it does not follow an open-access model, its comprehensive scope and valuable contributions to the medical and scientific community underscore its importance as an essential resource for advancing our understanding of microbial sciences.

Current Research in Microbial Sciences is a distinguished peer-reviewed journal published by Elsevier, focusing on the dynamic and rapidly advancing fields of microbiology and infectious diseases. With an ISSN of 2666-5174, this journal has established itself as an essential resource for researchers, professionals, and students alike, offering the latest findings and insights from 2020 to 2024. The journal holds a significant position in the academic landscape, achieving a Q2 ranking across multiple categories, including Immunology and Microbiology, Infectious Diseases, and Medical Microbiology, demonstrating its impact in these critical areas of study. With impressive Scopus rankings—such as being placed in the 94th percentile for Immunology and Microbiology—current research is well-supported by a thriving scientific community. Although the journal is not open access, it serves as a vital platform for disseminating high-quality research and fostering collaboration within the microbial sciences. Engaging with this journal enables professionals and researchers to stay abreast of innovations and contribute to the collective body of knowledge that shapes our understanding of microbial interactions and infectious diseases.